Bioorthogonal Engineering of Tumors with Bacterial Antigens Leverages Innate Immunity for Enhanced Adoptive T Cell Therapy

Substantial efforts in adoptive T-cell therapy have centered on boosting T-cell activity against tumors. However, a crucial yet overlooked factor is that the onset and maintenance of T-cell responses are highly dependent on innate immunity. Here, we developed a strategy of engineering tumors with bacterial antigens via click chemistry to cross-regulate innate-adaptive immunity, thereby enhancing the efficacy of adoptive T-cell therapy in solid tumors. The targeted delivery of bacterial antigens is mediated by azido sugar liposomes (TALP) for introducing azide groups on tumors and dibenzocyclooctyne-decorated bacterial membranes (DBCO-BM) to endow tumor cells with the innate immunogenicity of bacteria. Our study reveals that tumors with exposed bacterial antigens trigger innate immune responses for direct tumor killing and drive T-cell tumor infiltration to launch adaptive immunity. The antitumor functions of adoptive T cells are significantly augmented with the cross-activation of innate-adaptive immunity. This study highlights the potential of innate immunity in addressing the suboptimal response of adoptive T cells in solid tumors.

Authors

Institutions

Publication Details

Journal
ACS Nano
Published
2026-11-20
DOI
https://doi.org/10.1021/acsnano.6c18896
Primary Topic
Immunotherapy and Immune Responses
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Bioorthogonal Engineering of Tumors with Bacterial Antigens Leverages Innate Immunity for Enhanced Adoptive T Cell Therapy

Wen Li, Xian‐Zheng Zhang, Ruilin Li, Ping Ji et al.
6 links
ACS Nano
Immunotherapy and Immune Responses
article

Bioorthogonal Engineering of Tumors with Bacterial Antigens Leverages Innate Immunity for Enhanced Adoptive T Cell Therapy

Wen Li, Xian‐Zheng Zhang, Ruilin Li, Ping Ji, Xuan Zeng, Wei-Qin Yao, Jun Feng, Wen-Fang Song
article en

Abstract

Substantial efforts in adoptive T-cell therapy have centered on boosting T-cell activity against tumors. However, a crucial yet overlooked factor is that the onset and maintenance of T-cell responses are highly dependent on innate immunity. Here, we developed a strategy of engineering tumors with bacterial antigens via click chemistry to cross-regulate innate-adaptive immunity, thereby enhancing the efficacy of adoptive T-cell therapy in solid tumors. The targeted delivery of bacterial antigens is mediated by azido sugar liposomes (TALP) for introducing azide groups on tumors and dibenzocyclooctyne-decorated bacterial membranes (DBCO-BM) to endow tumor cells with the innate immunogenicity of bacteria. Our study reveals that tumors with exposed bacterial antigens trigger innate immune responses for direct tumor killing and drive T-cell tumor infiltration to launch adaptive immunity. The antitumor functions of adoptive T cells are significantly augmented with the cross-activation of innate-adaptive immunity. This study highlights the potential of innate immunity in addressing the suboptimal response of adoptive T cells in solid tumors.

ACS Nano
Wuhan University (CN)
National Natural Science Foundation of China
Good health and well-being
Immunotherapy and Immune Responses
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Bioorthogonal Engineering of Tumors with Bacterial Antigens Leverages Innate Immunity for Enhanced Adoptive T Cell Therapy — Wen Li, Xian‐Zheng Zhang, et al. · ACS Nano (2026) | TGRS Research Map | TGRS